-
Signature
-
/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp
-
Stock symbol
-
PCTY
-
Transactions as of
-
May 15, 2025
-
Transactions value $
-
-$6,300,552
-
Form type
-
4
-
Date filed
-
5/19/2025, 04:13 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Beauchamp Steven R |
Executive Chairman, Director |
C/O 1400 AMERICAN LANE, SCHAUMBURG |
/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp |
2025-05-19 |
0001314830 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PCTY |
Common Stock, par value $0.001 |
Sale |
-$5.64M |
-28.3K |
-1.82% |
$199.16 |
1.53M |
May 15, 2025 |
Direct |
F1, F2 |
| transaction |
PCTY |
Common Stock, par value $0.001 |
Tax liability |
-$326K |
-1.63K |
-0.11% |
$199.47 |
1.52M |
May 15, 2025 |
Direct |
|
| transaction |
PCTY |
Common Stock, par value $0.001 |
Sale |
-$333K |
-1.67K |
-0.11% |
$199.29 |
1.52M |
May 16, 2025 |
Direct |
F1, F3 |
| holding |
PCTY |
Common Stock, par value $0.001 |
|
|
|
|
|
235K |
May 15, 2025 |
by IRIE Family Trust |
F4 |
| holding |
PCTY |
Common Stock, par value $0.001 |
|
|
|
|
|
100K |
May 15, 2025 |
by Steven Beauchamp 2025 GRAT |
F5 |
| holding |
PCTY |
Common Stock, par value $0.001 |
|
|
|
|
|
69.1K |
May 15, 2025 |
by Gotham Triple Advantage Strategy LP |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: